ReviewJournal of clinical medicine2021

Prioritization of Novel Agents for Patients with Rhabdomyosarcoma: A Report from the Children's Oncology Group (COG) New Agents for Rhabdomyosarcoma Task Force.

Holly L Pacenta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.